Axcelead logo — Uniting scientific excellence, top-tier IP protection, and a...

Axcelead

Uniting scientific excellence, top-tier IP protection, and advanced GLP accredited facilities to provide seamless early discovery solutions.

Founded 2017 Seed Biotechnology, Health Care +1

General Information

Company Name Axcelead
Founded Year 2017
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Axcelead. To contact Axcelead, visit axcelead.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Axcelead compare?

A PDF of Axcelead and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Axcelead soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Axcelead

Axcelead is a biotech startup that aims to revolutionize drug discovery through their seamless early discovery solutions. Founded in 2017, the company has garnered attention for its commitment to uniting scientific excellence, top-tier IP protection, and advanced GLP accredited facilities. This combination of factors positions Axcelead as a formidable player in the biotechnology, healthcare, and pharmaceutical industries. The company's recent Seed Round investment in November 2018, led by Takeda Pharma, demonstrates a strong vote of confidence in the potential of Axcelead. This strategic partnership will provide the necessary resources to further develop the company's capabilities and solidify its position within the industry. With a compelling vision and notable backing, Axcelead is positioned to make a significant impact in the drug discovery landscape.

Business keywords: Drug discovery, Scientific excellence, IP protection, GLP accreditation, Early discovery solutions, Integrated capabilities, Pharmaceuticals, Research and development, Innovation, Life sciences, Biomedical technology

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 1
Takeda Pharma
01 Nov 2018

Axcelead Alternatives & Competitors

View All Alternatives
Axcelead vs
hVIVO
hVIVO United Kingdom

A rapidly growing early-stage Contract Research Organisation (CRO) and the global leader in human ch...

Series B
248 employees
Biotechnology, Health Care
Axcelead vs

Apply today https://jubilantcareer.jubl.com/

7249 employees
Health Care, Pharmaceutical
Axcelead vs
Aptamer Group
Aptamer Group United Kingdom

We develop Optimer® binders to enable innovation across the life science industry.

Post-IPO Equity
38 employees
Biotechnology, Health Care

FAQ About Axcelead

Uniting scientific excellence, top-tier IP protection, and advanced GLP accredited facilities to provide seamless early discovery solutions.
Axcelead was founded in 2017.
Axcelead operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Drug discovery, Scientific excellence, IP protection and GLP accreditation.
Axcelead has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Axcelead include hVIVO, Jubilant Pharmova Limited, Aptamer Group, TRELYS, BenevolentAI. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Axcelead and hVIVO are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Axcelead, https://bouncewatch.com/company/axcelead, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes